Dr. Klausner is currently founder and Chief Scientist of Altos Labs and founder and Chairman of Lyell Immunopharma, Inc. He is President of the Milky Way Research Foundation and founder and Managing Partner of Milky Way Investments. He was founder and Director of Juno Therapeutics and founder and Director of GRAIL. He is Chairman of Sonoma Biotherapeutics. Co-Founder and Chairman of Lifemine Therapeutics. He is the former Senior Vice President, Chief Medical Officer, and Chief Opportunity Officer of Illumina Corporation. Previously, he was Executive Director for Global Health of the Bill and Melinda Gates Foundation. Dr. Klausner was appointed by Presidents Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development as well as a past president of the American Society of Clinical Investigation. He has served in senior advisory roles to the US, Norwegian, Qatari and Indian governments.